10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,691,415 | -13.2% | 41,004 | +17.5% | 0.08% | -11.7% |
| Q2 2023 | $1,949,095 | +46.2% | 34,905 | +46.1% | 0.09% | +30.6% |
| Q1 2023 | $1,333,102 | +258.1% | 23,895 | +133.9% | 0.07% | +213.0% |
| Q4 2022 | $372,271 | -26.0% | 10,216 | -42.2% | 0.02% | -30.3% |
| Q3 2022 | $503,000 | -35.1% | 17,666 | +3.1% | 0.03% | -21.4% |
| Q2 2022 | $775,000 | -32.8% | 17,136 | +13.0% | 0.04% | -16.0% |
| Q1 2022 | $1,153,000 | -75.3% | 15,160 | -51.6% | 0.05% | -77.3% |
| Q4 2021 | $4,668,000 | +43.9% | 31,337 | +40.6% | 0.22% | +20.2% |
| Q3 2021 | $3,244,000 | +4.6% | 22,284 | +24.0% | 0.18% | -14.1% |
| Q2 2021 | $3,100,000 | – | 17,967 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |